RJF Stock Overview
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for RJF from our risk checks.
Laboratorio Reig Jofre, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.55 |
| 52 Week High | €2.88 |
| 52 Week Low | €2.15 |
| Beta | 0.89 |
| 1 Month Change | -1.92% |
| 3 Month Change | 9.44% |
| 1 Year Change | -0.39% |
| 3 Year Change | -50.58% |
| 5 Year Change | 3.24% |
| Change since IPO | -33.25% |
Recent News & Updates
Recent updates
These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively
Feb 02
This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts
Mar 07We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt
Mar 07Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly
May 17The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?
Mar 07Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?
Jan 14Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year
Dec 05Shareholder Returns
| RJF | ES Pharmaceuticals | ES Market | |
|---|---|---|---|
| 7D | 2.0% | 1.1% | 1.6% |
| 1Y | -0.4% | 40.0% | 16.8% |
Return vs Industry: RJF underperformed the Spanish Pharmaceuticals industry which returned 40% over the past year.
Return vs Market: RJF underperformed the Spanish Market which returned 17.9% over the past year.
Price Volatility
| RJF volatility | |
|---|---|
| RJF Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in ES Market | 6.9% |
| 10% least volatile stocks in ES Market | 1.1% |
Stable Share Price: RJF has not had significant price volatility in the past 3 months.
Volatility Over Time: RJF's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1929 | 1,331 | Ignasi Reig | www.reigjofre.com |
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers medical devices, cosmetics, parapharmacy, and animal food related products; and biotechnological and health products. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, joint health and pain, women’s health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand.
Laboratorio Reig Jofre, S.A. Fundamentals Summary
| RJF fundamental statistics | |
|---|---|
| Market cap | €200.94m |
| Earnings (TTM) | €9.41m |
| Revenue (TTM) | €317.95m |
21.4x
P/E Ratio0.6x
P/S RatioIs RJF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RJF income statement (TTM) | |
|---|---|
| Revenue | €317.95m |
| Cost of Revenue | €141.06m |
| Gross Profit | €176.89m |
| Other Expenses | €167.48m |
| Earnings | €9.41m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 55.63% |
| Net Profit Margin | 2.96% |
| Debt/Equity Ratio | 19.0% |
How did RJF perform over the long term?
See historical performance and comparison